Splenic MDSCs were isolated from the treated mice on day 4 after therapy and sorted for coculture with CD4+ T cells from tumor-bearing mice at a ratio of 1:5, and the subsets of CD4+ T cells were analyzed after 24 h (Figure 3F). The gene discussed is CD4; the disease is neoplasm.